Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

By Yokoyama Yoshihito   Xin Bing   Shigeto Tatsuhiko   Mizunuma Hideki  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1219-1228

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ ligand inhibits cell growth and invasion of human pancreatic cancer cells

By Hashimoto Koji   Ethridge Richard   Evers B.  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 7-22

Humana Press, Inc

Access to resources Recommend Favorite

Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Modulates Human Endometrial Cancer Cell Survival

By Ma J.   Monsivais D.   Dyson M.   Coon J.   Malpani S.   Ono M.   Zhao H.   Xin H.   Pavone M.   Kim J.   Chakravarti D.   Bulun S.  

Hormones and Cancer, Vol. 4, Iss. 6, 2013-12 ,pp. : 358-370

Springer Publishing Company

Access to resources Recommend Favorite

Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line

By                

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2239-2246

Spandidos Publications

Access to resources Recommend Favorite

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma

By Lee T.W.   Chen G.G.   Xu H.   Yip J.H.Y.   Chak E.C.W.   Mok T.S.K.   Yim A.P.C.  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1296-1301

Elsevier

Access to resources Recommend Favorite